The global biopharmaceutical market size was estimated at USD 484.38 million in 2025 and is projected to reach USD 816.30 million by 2033, growing at a CAGR of 6.55% from 2026 to 2033. The biopharmaceutical industry's growth is driven by increasing demand for targeted therapies, advancem... Read More »
December 2025The global anti-pollution nasal spray market size was estimated at USD 8.35 billion in 2025 and is projected to reach USD 13.30 billion by 2033, growing at a CAGR of 6.10% from 2026 to 2033. The high air pollution levels globally, driven by industrialization, urbanization, and rising veh... Read More »
December 2025The global Keytruda market size was estimated at USD 31.38 billion in 2025 and is projected to reach USD 24.95 billion by 2033, declining at a CAGR of -3.80% from 2026 to 2033. The market outlook for Keytruda (pembrolizumab) is expected to soften after its patent expiry due to rising bio... Read More »
December 2025The global anticoagulants market size was estimated at USD 37.35 billion in 2025 and is projected to reach USD 55.72 billion by 2033, growing at a CAGR of 5.26% from 2026 to 2033. The rising prevalence of cardiovascular diseases, such as Deep Vein Thrombosis (DVT), Pulmonary Em... Read More »
December 2025The global personalized testing & supplements market size was estimated at USD 13.58 billion in 2025 and is projected to reach USD 46.33 billion by 2033, growing at a CAGR of 16.72% from 2026 to 2033. The market has experienced significant growth due to the increasing consumer demand... Read More »
December 2025The global GLP-1 receptor agonist market size was estimated at USD 70.08 billion in 2025 and is projected to reach USD 201.79 billion by 2033, growing at a CAGR of 12.78% from 2026 to 2033. The launch of new glucagon-like peptide 1 (GLP-1) receptor agonist products, a robust product pipe... Read More »
December 2025The global cannabidiol market size was estimated at USD 10.68 billion in 2025 and is projected reach USD 30.96 billion by 2033, growing at a CAGR of 13.70% from 2026 to 2033. The market growth is driven by increasing consumer awareness of the potential therapeutic benefits of cannabidiol... Read More »
December 2025The U.S. plant-based API market size was estimated at USD 9.69 billion in 2024 and is projected to reach USD 15.77 billion by 2033, growing at a CAGR of 5.5% from 2025 to 2033. The market is witnessing strong growth due to the increasing adoption of natural and sustainable pharmaceutical... Read More »
December 2025The global plant-based API market size was estimated at USD 31.78 billion in 2024 and is projected to reach USD 53.21 billion by 2033, growing at a CAGR of 5.9% from 2025 to 2033. The market is progressing steadily as pharmaceutical companies shift toward natural-origin ingredients suppo... Read More »
December 2025The global breast cancer drugs market size was estimated at USD 36.62 billion in 2024 and is projected to reach USD 69.72 billion by 2033, growing at a CAGR of 7.09% from 2025 to 2033. The market is driven by several critical factors, including the increasing global incidence of breast c... Read More »
December 2025The global insomnia supplements market size was estimated at USD 4.29 billion in 2024 and is projected to reach USD 12.55 billion by 2033, growing at a CAGR of 12.94% from 2025 to 2033. Growing awareness around the impact of poor sleep on overall health has become a major catalyst for in... Read More »
November 2025The U.S. autism spectrum disorder treatment market size was estimated at USD 827.84 million in 2024 and is projected to reach USD 1,431.60 million by 2033, growing at a CAGR of 6.30% from 2025 to 2033. The increasing diagnosis rates and wider access to therapeutic services drive the grow... Read More »
November 2025The Middle East bone and joint health supplements market size was estimated at USD 262.7 million in 2024 and is projected to reach USD 408.7 million by 2033, growing at a CAGR of 5.04% from 2025 to 2033. Market growth is driven by the rising prevalence of osteoporosis and joint disorders... Read More »
November 2025The U.S. osteoarthritis therapeutics market size was estimated at USD 2.15 billion in 2024 and is projected to reach USD 4.50 billion by 2033, growing at a CAGR of 8.61% from 2025 to 2033. Growing geriatric population, rising prevalence of obesity and joint injuries, and increasing deman... Read More »
November 2025The global urinary incontinence therapeutics market size was estimated at USD 4.32 billion in 2024 and is projected to reach USD 6.95 billion by 2033, growing at a CAGR of 5.4% from 2025 to 2033. This growth is primarily driven by the increasing prevalence of urinary incontinence among a... Read More »
November 2025The global autism spectrum disorder treatment market size was estimated at USD 2.16 billion in 2024 and is projected to reach USD 3.95 billion by 2033, growing at a CAGR of 6.92% from 2025 to 2033. The Autism Spectrum Disorder (ASD) treatment market is advancing due to an increasing numb... Read More »
November 2025The global immune health supplements market size was estimated at USD 35.35 billion in 2024 and is projected to reach USD 76.23 billion by 2033, growing at a CAGR of 9.06% from 2025 to 2033. The key factors driving market growth include the increasing prevalence of infectious diseases, d... Read More »
November 2025The Saudi Arabia total parenteral nutrition market size was valued at USD 94.64 million in 2024 and is projected to USD 155.64 million by 2033, growing at a CAGR of 5.71% from 2025 to 2033. The rising prevalence of chronic diseases and the increasing number of premature births are signif... Read More »
November 2025The U.S. urinary incontinence therapeutics market size was estimated at USD 1.55 billion in 2024 and is projected to reach USD 2.41 billion by 2033, growing at a CAGR of 5.06% from 2025 to 2033. The U.S. market is expanding as demand for advanced treatment options rises across key patien... Read More »
November 2025The U.S. leukemia therapeutics market size was estimated at USD 7.23 billion in 2024 and is projected to reach USD 13.07 billion by 2033, growing at a CAGR of 6.80% from 2025 to 2033. The industry is expanding due to the strong adoption of targeted therapies that offer high clinical prec... Read More »
November 2025